publication date: Dec. 23, 2010

In this issue: 

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

Campus-Dweller Rabson Finds Comfort In NIH Security.

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

Myriad In Partnership To Market Products.

Computer-Aided Detection Approved For Mammograms.

Download (PDF 451KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.